For decades, capital allocation has largely been reactive. Systems absorb cost once problems emerge, chronic illness, cognitive decline, workforce instability. Prevention has traditionally been treated as a social expense rather than a strategic investment.
That framing is beginning to shift, and not just in theory.
From Theory to Practice
Over the past decade, outcome-based financing models have begun testing the Prevention approach in real-world settings. One of the most cited examples is the South Carolina Nurse-Family Partnership Pay for Success initiative, where private capital funded nurse home-visiting programs for low-income mothers. If measurable outcomes, (such as reduced preterm births and improved maternal health) were achieved, the state agreed to repay investors using public savings from reduced healthcare and social service costs.
Similarly, Massachusetts launched one of the first U.S. social impact bonds targeting juvenile justice recidivism, tying investor returns to reduced incarceration rates. It is an example of capital being deployed to reduce downstream public expenditure.
In healthcare, the Centers for Medicare & Medicaid Services (CMS) have expanded value-based payment models to reward providers for preventing hospital readmissions and managing chronic disease more effectively. While not traditional “impact bonds,” these structures reflect the same shift: funding better outcomes rather than reimbursing volume.
The premise underlying these initiatives is consistent: avoided cost can be structured as measurable economic value.
Health Economics
The economic case for early intervention is not new. Nobel laureate economist James Heckman’s research demonstrated that investments in early childhood development generate some of the highest returns in public policy, often exceeding 7–10% annually when long-term impacts are considered (Heckman, 2006).
Prenatal and early childhood health are particularly influential. Research by Almond and Currie (2011) shows that health conditions in utero and early life significantly affect adult earnings, educational attainment, and labor participation.
In the context of Alzheimer’s disease, the numbers are equally compelling. The total economic cost of dementia in the United States exceeds $250 billion annually (Hurd et al., 2013). Research suggests that delaying the onset of Alzheimer’s by even five years could reduce prevalence by nearly 40% and dramatically lower long-term care expenditures (Zissimopoulos et al., 2014).
These findings increasingly influence conversations among policymakers, insurers, and institutional investors alike.
Signals from Policy Circles
Beyond specific programs, prevention-as-investment is appearing in broader economic research.
Several regional Federal Reserve banks, including Minneapolis and Richmond, have published research on early childhood investment as a driver of long-term labor force participation and economic resilience. While the Federal Reserve does not fund such programs directly, the research reflects a growing macroeconomic understanding: human capital formation influences productivity, fiscal stability, and long-term growth.
Healthy populations support stable workforces.
Stable workforces support fiscal systems.
The systems are interconnected.
A Broader Reframing
What began as social policy experimentation is gradually becoming a capital design question. Whether applied to maternal health, Alzheimer’s prevention, climate adaptation, or regenerative infrastructure, the principle remains consistent, we must invest earlier, measure outcomes, and strengthen long-term stability.
In an era defined by volatility and rising long-term liabilities, prevention is increasingly being viewed not simply as a moral imperative , but as economic architecture.
What surfaced in conversations at global convenings may reflect something deeper: a structural reframing of how capital is deployed in complex systems.
Prevention, once treated as a line item, may prove to be one of the most underleveraged forms of infrastructure.
